GlassScriptPhysician profile
Chi Mong C Or
NPI 1639676000
$10,354.38
in general payments reported to CMS, 2019-2025
18 companies · $4,145 in 2025
The $4,145 reported for 2025 was more than what 93% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $160 · 2022: $1,530 · 2023: $1,796 · 2024: $2,724 · 2025: $4,145.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,140 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,550 · Honoraria: $1,275 · Consulting Fee: $700.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,140.19 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,550.00 |
| Honoraria | $1,275.00 |
| Consulting Fee | $700.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mallinckrodt Hospital Products INC. | $3,177.93 | 2021-2025 | Acthar |
| Ani Pharmaceuticals, INC. | $2,182.82 | 2022-2025 | Purified Cortrophin Gel, Yutiq, Iluvien |
| Apellis Pharmaceuticals, INC. | $1,007.91 | 2022-2025 | Syfovre |
| Harrow Eye, LLC | $738.64 | 2025 | Triesence, Vevye |
| Alimera Sciences, INC. | $687.07 | 2022-2024 | Iluvien, Yutiq |
| Astellas Pharma US INC | $542.38 | 2023-2025 | Izervay |
| Biogen, INC. | $334.93 | 2022-2023 | |
| Ocular Therapeutix, INC. | $317.40 | 2023-2025 | Dextenza |
| Regeneron Pharmaceuticals, INC. | $303.92 | 2022-2023 | Eylea Hd |
| Abbvie INC. | $248.70 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $213.40 | 2022-2023 | Eylea Hd |
| Spark Therapeutics, INC. | $154.98 | 2022 | |
| Dutch Ophthalmic, USA | $149.46 | 2022 | |
| Genentech, INC. | $94.08 | 2022 | |
| Oyster Point Pharma, INC. | $82.69 | 2023-2024 | Tyrvaya |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Rxsight INC | $69.49 | 2025 | Rxsight Injector Cartridge, Light Adjustable Lens (Lal), Rxsight Contact Lens |
| Johnson & Johnson Surgical Vision, INC. | $36.31 | 2025 | Tecnis Iol |
| Alcon Vision LLC | $12.27 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chi Mong Or listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.